PhoenixBio Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	1,053	1,149	1,384	1,555	1,325	1,327
Cash & Short-Term Investments	1,053	1,149	1,384	1,555	1,325	1,327
Cash Growth	-7.31%	-16.98%	-11.00%	17.36%	-0.15%	-25.24%
Receivables	197	170	217	286	226	159
Inventory	320	333	450	365	258	279
Other Current Assets	68	65	81	86	45	34
Total Current Assets	1,638	1,717	2,132	2,292	1,854	1,799
Property, Plant & Equipment	527	527	542	538	409	702
Long-Term Investments	14	12	15	145	11	10
Other Intangible Assets	16	18	10	5	1	2
Long-Term Deferred Tax Assets	-	9	14	37	3	2
Other Long-Term Assets	2	2	2	1	2	1
Total Assets	2,197	2,285	2,715	3,018	2,280	2,516
Accounts Payable	19	16	12	40	37	37
Accrued Expenses	5	7	7	4	-	-
Short-Term Debt	100	100	100	-	-	-
Current Portion of Long-Term Debt	79	79	79	875	-	2
Current Portion of Leases	-	32	52	40	30	25
Current Income Taxes Payable	14	11	4	63	12	6
Other Current Liabilities	171	321	167	264	359	328
Total Current Liabilities	388	566	421	1,286	438	398
Long-Term Debt	160	220	300	-	900	900
Long-Term Leases	-	133	191	214	107	110
Long-Term Deferred Tax Liabilities	-	-	1	-	-	5
Other Long-Term Liabilities	133	2	6	4	7	10
Total Liabilities	681	921	919	1,504	1,452	1,423
Common Stock	2,573	2,569	2,562	2,453	2,363	2,358
Additional Paid-In Capital	793	789	782	673	583	578
Retained Earnings	-1,939	-2,032	-1,584	-1,610	-2,103	-1,796
Comprehensive Income & Other	89	38	36	-2	-15	-47
Shareholders' Equity	1,516	1,364	1,796	1,514	828	1,093
Total Liabilities & Equity	2,197	2,285	2,715	3,018	2,280	2,516
Total Debt	339	564	722	1,129	1,037	1,037
Net Cash (Debt)	714	585	662	426	288	290
Net Cash Growth	-0.42%	-11.63%	55.40%	47.92%	-0.69%	-37.09%
Net Cash Per Share	176.85	144.64	175.05	84.01	87.22	89.68
Filing Date Shares Outstanding	4.07	4.05	4.03	3.63	3.31	3.29
Total Common Shares Outstanding	4.07	4.05	4.03	3.63	3.31	3.29
Working Capital	1,250	1,151	1,711	1,006	1,416	1,401
Book Value Per Share	372.46	336.75	445.87	416.65	250.37	332.40
Tangible Book Value	1,500	1,346	1,786	1,509	827	1,091
Tangible Book Value Per Share	368.53	332.30	443.39	415.27	250.07	331.80
Order Backlog	-	1,098	714.23	454.65	1,168	548.08

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.